Management of gallstones and gallbladder disease in patients undergoing gastric bypass.
The appropriate management of gallstones and gallbladder disease in patients undergoing gastric bypass remains unknown. Several therapeutic modalities are used and include performing cholecystectomy on all patients at the time of gastric bypass, performing concomitant cholecystectomy only when patients have gallstones and performing cholecystectomy only in the presence of both symptoms and gallstones. Some groups administer ursodeoxycholic acid for gallstone prevention in the postoperative period. All treatment modalities are analyzed and their results and rationality are discussed.
Quesada
Bernabé M
BM
Kohan
Gustavo
G
Roff
Hernán E
HE
Canullán
Carlos M
CM
Chiappetta Porras
Luis T
LT
D002756:Cholagogues and Choleretics / Q000494:pharmacology; D002763:Cholecystectomy; D005705:Gallbladder Diseases / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D042882:Gallstones / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D015390:Gastric Bypass / Q000009:adverse effects*; D006801:Humans; D014580:Ursodeoxycholic Acid / Q000494:pharmacology
D002756:Cholagogues and Choleretics; D014580:Ursodeoxycholic Acid